Effects of a Thin-Sized Lead Body of a Transvenous Single Coil Defibrillation Lead on ICD Implantation
SCHUCHERT, A., et al.: Effects of a Thin-Sized Lead Body of a Transvenous Single Coil Defibrillation Lead on ICD Implantation. In the interest of patients receiving implantable cardioverter defibrillators (ICDs), the clinical benefits of newer and thinner transvenous defibrillation leads have to be...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
SCHUCHERT, ANDREAS [verfasserIn] MEINERTZ, THOMAS [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|
| Erschienen: |
Oxford, UK: Blackwell Futura Publishing, Inc. ; 2000 |
|---|
| Schlagwörter: |
|---|
| Umfang: |
Online-Ressource |
|---|
| Reproduktion: |
2003 ; Blackwell Publishing Journal Backfiles 1879-2005 |
|---|---|
| Übergeordnetes Werk: |
In: Pacing and clinical electrophysiology - New York, NY [u.a.] : Wiley-Blackwell, 1978, 23(2000), 10, Seite 0 |
| Übergeordnetes Werk: |
volume:23 ; year:2000 ; number:10 ; pages:0 |
| Links: |
|---|
| DOI / URN: |
10.1046/j.1460-9592.2000.01468.x |
|---|
| Katalog-ID: |
NLEJ243910703 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLEJ243910703 | ||
| 003 | DE-627 | ||
| 005 | 20210707191323.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 120427s2000 xx |||||o 00| ||und c | ||
| 024 | 7 | |a 10.1046/j.1460-9592.2000.01468.x |2 doi | |
| 035 | |a (DE-627)NLEJ243910703 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 100 | 1 | |a SCHUCHERT, ANDREAS |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Effects of a Thin-Sized Lead Body of a Transvenous Single Coil Defibrillation Lead on ICD Implantation |
| 264 | 1 | |a Oxford, UK |b Blackwell Futura Publishing, Inc. |c 2000 | |
| 300 | |a Online-Ressource | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a SCHUCHERT, A., et al.: Effects of a Thin-Sized Lead Body of a Transvenous Single Coil Defibrillation Lead on ICD Implantation. In the interest of patients receiving implantable cardioverter defibrillators (ICDs), the clinical benefits of newer and thinner transvenous defibrillation leads have to be determined. The aims of this study were to evaluate the ICD procedure duration and the frequency of lead dislocation at the 3-month follow-up of a new defibrillation lead with a thin-sized lead body and its conventionalsized predecessor. The thin-sized single coil defibrillation lead (Kainox RV, Biotronik; lead body 6.7 Fr) was implanted in 61 patients and the conventional-sized defibrillation lead (SPS, Biotronik; lead body 7.8 Fr) in 60 patients. Both leads were connected to a left-sided, prepectorally implanted Phylax ICD (Biotronik) with active housing. The lead implantation time and total procedure duration were determined. Lead implantation time was defined as the time from lead insertion to the end of the pacing measurements. The total procedure duration spanned skin incision to closure. The incidence of lead repositioning during the lead implantation time and during ventricular fibrillation conversion testing was also assessed. The frequency of lead dislocations was recorded at the 3-month follow-up. Mean lead implantation time and total procedure duration of the thin-sized lead (23 ± 22 minutes 76 ± 37 minutes) were not statistically different from the time needed for the conventional-sized lead (22 ± 20 minutes 81 ± 34 minutes). The number of lead repositionings during the lead implantation time was similar (thin-sized lead: 1.4 ± 2.4; conventional-sized lead: 1.1 ± 1.9). An additional lead repositioning was not necessary during ventricular fibrillation conversion testing in 93.4% of the patients with thin-sized and in 94.4% with conventional-sized leads (not significant). At the 3-month follow-up, there were four (6.6%) lead dislocations in the thin-sized and four (6.7%) in the conventional-sized lead group. In conclusion, the downsized lead body of the new defibrillation lead influenced neither ICD procedure duration nor the incidence of lead dislocation during follow-up. | ||
| 533 | |d 2003 |f Blackwell Publishing Journal Backfiles 1879-2005 |7 |2003|||||||||| | ||
| 650 | 4 | |a implantable cardioverter defibrillator (ICD) | |
| 700 | 1 | |a MEINERTZ, THOMAS |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i In |t Pacing and clinical electrophysiology |d New York, NY [u.a.] : Wiley-Blackwell, 1978 |g 23(2000), 10, Seite 0 |h Online-Ressource |w (DE-627)NLEJ243926928 |w (DE-600)2037547-5 |x 1540-8159 |7 nnns |
| 773 | 1 | 8 | |g volume:23 |g year:2000 |g number:10 |g pages:0 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1046/j.1460-9592.2000.01468.x |q text/html |x Verlag |z Deutschlandweit zugänglich |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a ZDB-1-DJB | ||
| 912 | |a GBV_NL_ARTICLE | ||
| 951 | |a AR | ||
| 952 | |d 23 |j 2000 |e 10 |h 0 | ||
| author_variant |
a s as t m tm |
|---|---|
| matchkey_str |
article:15408159:2000----::fetoahnielabdoarnvnusnlcidfbilt |
| hierarchy_sort_str |
2000 |
| publishDate |
2000 |
| allfields |
10.1046/j.1460-9592.2000.01468.x doi (DE-627)NLEJ243910703 DE-627 ger DE-627 rakwb SCHUCHERT, ANDREAS verfasserin aut Effects of a Thin-Sized Lead Body of a Transvenous Single Coil Defibrillation Lead on ICD Implantation Oxford, UK Blackwell Futura Publishing, Inc. 2000 Online-Ressource nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier SCHUCHERT, A., et al.: Effects of a Thin-Sized Lead Body of a Transvenous Single Coil Defibrillation Lead on ICD Implantation. In the interest of patients receiving implantable cardioverter defibrillators (ICDs), the clinical benefits of newer and thinner transvenous defibrillation leads have to be determined. The aims of this study were to evaluate the ICD procedure duration and the frequency of lead dislocation at the 3-month follow-up of a new defibrillation lead with a thin-sized lead body and its conventionalsized predecessor. The thin-sized single coil defibrillation lead (Kainox RV, Biotronik; lead body 6.7 Fr) was implanted in 61 patients and the conventional-sized defibrillation lead (SPS, Biotronik; lead body 7.8 Fr) in 60 patients. Both leads were connected to a left-sided, prepectorally implanted Phylax ICD (Biotronik) with active housing. The lead implantation time and total procedure duration were determined. Lead implantation time was defined as the time from lead insertion to the end of the pacing measurements. The total procedure duration spanned skin incision to closure. The incidence of lead repositioning during the lead implantation time and during ventricular fibrillation conversion testing was also assessed. The frequency of lead dislocations was recorded at the 3-month follow-up. Mean lead implantation time and total procedure duration of the thin-sized lead (23 ± 22 minutes 76 ± 37 minutes) were not statistically different from the time needed for the conventional-sized lead (22 ± 20 minutes 81 ± 34 minutes). The number of lead repositionings during the lead implantation time was similar (thin-sized lead: 1.4 ± 2.4; conventional-sized lead: 1.1 ± 1.9). An additional lead repositioning was not necessary during ventricular fibrillation conversion testing in 93.4% of the patients with thin-sized and in 94.4% with conventional-sized leads (not significant). At the 3-month follow-up, there were four (6.6%) lead dislocations in the thin-sized and four (6.7%) in the conventional-sized lead group. In conclusion, the downsized lead body of the new defibrillation lead influenced neither ICD procedure duration nor the incidence of lead dislocation during follow-up. 2003 Blackwell Publishing Journal Backfiles 1879-2005 |2003|||||||||| implantable cardioverter defibrillator (ICD) MEINERTZ, THOMAS verfasserin aut In Pacing and clinical electrophysiology New York, NY [u.a.] : Wiley-Blackwell, 1978 23(2000), 10, Seite 0 Online-Ressource (DE-627)NLEJ243926928 (DE-600)2037547-5 1540-8159 nnns volume:23 year:2000 number:10 pages:0 http://dx.doi.org/10.1046/j.1460-9592.2000.01468.x text/html Verlag Deutschlandweit zugänglich Volltext GBV_USEFLAG_U ZDB-1-DJB GBV_NL_ARTICLE AR 23 2000 10 0 |
| spelling |
10.1046/j.1460-9592.2000.01468.x doi (DE-627)NLEJ243910703 DE-627 ger DE-627 rakwb SCHUCHERT, ANDREAS verfasserin aut Effects of a Thin-Sized Lead Body of a Transvenous Single Coil Defibrillation Lead on ICD Implantation Oxford, UK Blackwell Futura Publishing, Inc. 2000 Online-Ressource nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier SCHUCHERT, A., et al.: Effects of a Thin-Sized Lead Body of a Transvenous Single Coil Defibrillation Lead on ICD Implantation. In the interest of patients receiving implantable cardioverter defibrillators (ICDs), the clinical benefits of newer and thinner transvenous defibrillation leads have to be determined. The aims of this study were to evaluate the ICD procedure duration and the frequency of lead dislocation at the 3-month follow-up of a new defibrillation lead with a thin-sized lead body and its conventionalsized predecessor. The thin-sized single coil defibrillation lead (Kainox RV, Biotronik; lead body 6.7 Fr) was implanted in 61 patients and the conventional-sized defibrillation lead (SPS, Biotronik; lead body 7.8 Fr) in 60 patients. Both leads were connected to a left-sided, prepectorally implanted Phylax ICD (Biotronik) with active housing. The lead implantation time and total procedure duration were determined. Lead implantation time was defined as the time from lead insertion to the end of the pacing measurements. The total procedure duration spanned skin incision to closure. The incidence of lead repositioning during the lead implantation time and during ventricular fibrillation conversion testing was also assessed. The frequency of lead dislocations was recorded at the 3-month follow-up. Mean lead implantation time and total procedure duration of the thin-sized lead (23 ± 22 minutes 76 ± 37 minutes) were not statistically different from the time needed for the conventional-sized lead (22 ± 20 minutes 81 ± 34 minutes). The number of lead repositionings during the lead implantation time was similar (thin-sized lead: 1.4 ± 2.4; conventional-sized lead: 1.1 ± 1.9). An additional lead repositioning was not necessary during ventricular fibrillation conversion testing in 93.4% of the patients with thin-sized and in 94.4% with conventional-sized leads (not significant). At the 3-month follow-up, there were four (6.6%) lead dislocations in the thin-sized and four (6.7%) in the conventional-sized lead group. In conclusion, the downsized lead body of the new defibrillation lead influenced neither ICD procedure duration nor the incidence of lead dislocation during follow-up. 2003 Blackwell Publishing Journal Backfiles 1879-2005 |2003|||||||||| implantable cardioverter defibrillator (ICD) MEINERTZ, THOMAS verfasserin aut In Pacing and clinical electrophysiology New York, NY [u.a.] : Wiley-Blackwell, 1978 23(2000), 10, Seite 0 Online-Ressource (DE-627)NLEJ243926928 (DE-600)2037547-5 1540-8159 nnns volume:23 year:2000 number:10 pages:0 http://dx.doi.org/10.1046/j.1460-9592.2000.01468.x text/html Verlag Deutschlandweit zugänglich Volltext GBV_USEFLAG_U ZDB-1-DJB GBV_NL_ARTICLE AR 23 2000 10 0 |
| allfields_unstemmed |
10.1046/j.1460-9592.2000.01468.x doi (DE-627)NLEJ243910703 DE-627 ger DE-627 rakwb SCHUCHERT, ANDREAS verfasserin aut Effects of a Thin-Sized Lead Body of a Transvenous Single Coil Defibrillation Lead on ICD Implantation Oxford, UK Blackwell Futura Publishing, Inc. 2000 Online-Ressource nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier SCHUCHERT, A., et al.: Effects of a Thin-Sized Lead Body of a Transvenous Single Coil Defibrillation Lead on ICD Implantation. In the interest of patients receiving implantable cardioverter defibrillators (ICDs), the clinical benefits of newer and thinner transvenous defibrillation leads have to be determined. The aims of this study were to evaluate the ICD procedure duration and the frequency of lead dislocation at the 3-month follow-up of a new defibrillation lead with a thin-sized lead body and its conventionalsized predecessor. The thin-sized single coil defibrillation lead (Kainox RV, Biotronik; lead body 6.7 Fr) was implanted in 61 patients and the conventional-sized defibrillation lead (SPS, Biotronik; lead body 7.8 Fr) in 60 patients. Both leads were connected to a left-sided, prepectorally implanted Phylax ICD (Biotronik) with active housing. The lead implantation time and total procedure duration were determined. Lead implantation time was defined as the time from lead insertion to the end of the pacing measurements. The total procedure duration spanned skin incision to closure. The incidence of lead repositioning during the lead implantation time and during ventricular fibrillation conversion testing was also assessed. The frequency of lead dislocations was recorded at the 3-month follow-up. Mean lead implantation time and total procedure duration of the thin-sized lead (23 ± 22 minutes 76 ± 37 minutes) were not statistically different from the time needed for the conventional-sized lead (22 ± 20 minutes 81 ± 34 minutes). The number of lead repositionings during the lead implantation time was similar (thin-sized lead: 1.4 ± 2.4; conventional-sized lead: 1.1 ± 1.9). An additional lead repositioning was not necessary during ventricular fibrillation conversion testing in 93.4% of the patients with thin-sized and in 94.4% with conventional-sized leads (not significant). At the 3-month follow-up, there were four (6.6%) lead dislocations in the thin-sized and four (6.7%) in the conventional-sized lead group. In conclusion, the downsized lead body of the new defibrillation lead influenced neither ICD procedure duration nor the incidence of lead dislocation during follow-up. 2003 Blackwell Publishing Journal Backfiles 1879-2005 |2003|||||||||| implantable cardioverter defibrillator (ICD) MEINERTZ, THOMAS verfasserin aut In Pacing and clinical electrophysiology New York, NY [u.a.] : Wiley-Blackwell, 1978 23(2000), 10, Seite 0 Online-Ressource (DE-627)NLEJ243926928 (DE-600)2037547-5 1540-8159 nnns volume:23 year:2000 number:10 pages:0 http://dx.doi.org/10.1046/j.1460-9592.2000.01468.x text/html Verlag Deutschlandweit zugänglich Volltext GBV_USEFLAG_U ZDB-1-DJB GBV_NL_ARTICLE AR 23 2000 10 0 |
| allfieldsGer |
10.1046/j.1460-9592.2000.01468.x doi (DE-627)NLEJ243910703 DE-627 ger DE-627 rakwb SCHUCHERT, ANDREAS verfasserin aut Effects of a Thin-Sized Lead Body of a Transvenous Single Coil Defibrillation Lead on ICD Implantation Oxford, UK Blackwell Futura Publishing, Inc. 2000 Online-Ressource nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier SCHUCHERT, A., et al.: Effects of a Thin-Sized Lead Body of a Transvenous Single Coil Defibrillation Lead on ICD Implantation. In the interest of patients receiving implantable cardioverter defibrillators (ICDs), the clinical benefits of newer and thinner transvenous defibrillation leads have to be determined. The aims of this study were to evaluate the ICD procedure duration and the frequency of lead dislocation at the 3-month follow-up of a new defibrillation lead with a thin-sized lead body and its conventionalsized predecessor. The thin-sized single coil defibrillation lead (Kainox RV, Biotronik; lead body 6.7 Fr) was implanted in 61 patients and the conventional-sized defibrillation lead (SPS, Biotronik; lead body 7.8 Fr) in 60 patients. Both leads were connected to a left-sided, prepectorally implanted Phylax ICD (Biotronik) with active housing. The lead implantation time and total procedure duration were determined. Lead implantation time was defined as the time from lead insertion to the end of the pacing measurements. The total procedure duration spanned skin incision to closure. The incidence of lead repositioning during the lead implantation time and during ventricular fibrillation conversion testing was also assessed. The frequency of lead dislocations was recorded at the 3-month follow-up. Mean lead implantation time and total procedure duration of the thin-sized lead (23 ± 22 minutes 76 ± 37 minutes) were not statistically different from the time needed for the conventional-sized lead (22 ± 20 minutes 81 ± 34 minutes). The number of lead repositionings during the lead implantation time was similar (thin-sized lead: 1.4 ± 2.4; conventional-sized lead: 1.1 ± 1.9). An additional lead repositioning was not necessary during ventricular fibrillation conversion testing in 93.4% of the patients with thin-sized and in 94.4% with conventional-sized leads (not significant). At the 3-month follow-up, there were four (6.6%) lead dislocations in the thin-sized and four (6.7%) in the conventional-sized lead group. In conclusion, the downsized lead body of the new defibrillation lead influenced neither ICD procedure duration nor the incidence of lead dislocation during follow-up. 2003 Blackwell Publishing Journal Backfiles 1879-2005 |2003|||||||||| implantable cardioverter defibrillator (ICD) MEINERTZ, THOMAS verfasserin aut In Pacing and clinical electrophysiology New York, NY [u.a.] : Wiley-Blackwell, 1978 23(2000), 10, Seite 0 Online-Ressource (DE-627)NLEJ243926928 (DE-600)2037547-5 1540-8159 nnns volume:23 year:2000 number:10 pages:0 http://dx.doi.org/10.1046/j.1460-9592.2000.01468.x text/html Verlag Deutschlandweit zugänglich Volltext GBV_USEFLAG_U ZDB-1-DJB GBV_NL_ARTICLE AR 23 2000 10 0 |
| allfieldsSound |
10.1046/j.1460-9592.2000.01468.x doi (DE-627)NLEJ243910703 DE-627 ger DE-627 rakwb SCHUCHERT, ANDREAS verfasserin aut Effects of a Thin-Sized Lead Body of a Transvenous Single Coil Defibrillation Lead on ICD Implantation Oxford, UK Blackwell Futura Publishing, Inc. 2000 Online-Ressource nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier SCHUCHERT, A., et al.: Effects of a Thin-Sized Lead Body of a Transvenous Single Coil Defibrillation Lead on ICD Implantation. In the interest of patients receiving implantable cardioverter defibrillators (ICDs), the clinical benefits of newer and thinner transvenous defibrillation leads have to be determined. The aims of this study were to evaluate the ICD procedure duration and the frequency of lead dislocation at the 3-month follow-up of a new defibrillation lead with a thin-sized lead body and its conventionalsized predecessor. The thin-sized single coil defibrillation lead (Kainox RV, Biotronik; lead body 6.7 Fr) was implanted in 61 patients and the conventional-sized defibrillation lead (SPS, Biotronik; lead body 7.8 Fr) in 60 patients. Both leads were connected to a left-sided, prepectorally implanted Phylax ICD (Biotronik) with active housing. The lead implantation time and total procedure duration were determined. Lead implantation time was defined as the time from lead insertion to the end of the pacing measurements. The total procedure duration spanned skin incision to closure. The incidence of lead repositioning during the lead implantation time and during ventricular fibrillation conversion testing was also assessed. The frequency of lead dislocations was recorded at the 3-month follow-up. Mean lead implantation time and total procedure duration of the thin-sized lead (23 ± 22 minutes 76 ± 37 minutes) were not statistically different from the time needed for the conventional-sized lead (22 ± 20 minutes 81 ± 34 minutes). The number of lead repositionings during the lead implantation time was similar (thin-sized lead: 1.4 ± 2.4; conventional-sized lead: 1.1 ± 1.9). An additional lead repositioning was not necessary during ventricular fibrillation conversion testing in 93.4% of the patients with thin-sized and in 94.4% with conventional-sized leads (not significant). At the 3-month follow-up, there were four (6.6%) lead dislocations in the thin-sized and four (6.7%) in the conventional-sized lead group. In conclusion, the downsized lead body of the new defibrillation lead influenced neither ICD procedure duration nor the incidence of lead dislocation during follow-up. 2003 Blackwell Publishing Journal Backfiles 1879-2005 |2003|||||||||| implantable cardioverter defibrillator (ICD) MEINERTZ, THOMAS verfasserin aut In Pacing and clinical electrophysiology New York, NY [u.a.] : Wiley-Blackwell, 1978 23(2000), 10, Seite 0 Online-Ressource (DE-627)NLEJ243926928 (DE-600)2037547-5 1540-8159 nnns volume:23 year:2000 number:10 pages:0 http://dx.doi.org/10.1046/j.1460-9592.2000.01468.x text/html Verlag Deutschlandweit zugänglich Volltext GBV_USEFLAG_U ZDB-1-DJB GBV_NL_ARTICLE AR 23 2000 10 0 |
| source |
In Pacing and clinical electrophysiology 23(2000), 10, Seite 0 volume:23 year:2000 number:10 pages:0 |
| sourceStr |
In Pacing and clinical electrophysiology 23(2000), 10, Seite 0 volume:23 year:2000 number:10 pages:0 |
| format_phy_str_mv |
Article |
| institution |
findex.gbv.de |
| topic_facet |
implantable cardioverter defibrillator (ICD) |
| isfreeaccess_bool |
false |
| container_title |
Pacing and clinical electrophysiology |
| authorswithroles_txt_mv |
SCHUCHERT, ANDREAS @@aut@@ MEINERTZ, THOMAS @@aut@@ |
| publishDateDaySort_date |
2000-01-01T00:00:00Z |
| hierarchy_top_id |
NLEJ243926928 |
| id |
NLEJ243910703 |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">NLEJ243910703</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20210707191323.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">120427s2000 xx |||||o 00| ||und c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1046/j.1460-9592.2000.01468.x</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)NLEJ243910703</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">SCHUCHERT, ANDREAS</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Effects of a Thin-Sized Lead Body of a Transvenous Single Coil Defibrillation Lead on ICD Implantation</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Oxford, UK</subfield><subfield code="b">Blackwell Futura Publishing, Inc.</subfield><subfield code="c">2000</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">SCHUCHERT, A., et al.: Effects of a Thin-Sized Lead Body of a Transvenous Single Coil Defibrillation Lead on ICD Implantation. In the interest of patients receiving implantable cardioverter defibrillators (ICDs), the clinical benefits of newer and thinner transvenous defibrillation leads have to be determined. The aims of this study were to evaluate the ICD procedure duration and the frequency of lead dislocation at the 3-month follow-up of a new defibrillation lead with a thin-sized lead body and its conventionalsized predecessor. The thin-sized single coil defibrillation lead (Kainox RV, Biotronik; lead body 6.7 Fr) was implanted in 61 patients and the conventional-sized defibrillation lead (SPS, Biotronik; lead body 7.8 Fr) in 60 patients. Both leads were connected to a left-sided, prepectorally implanted Phylax ICD (Biotronik) with active housing. The lead implantation time and total procedure duration were determined. Lead implantation time was defined as the time from lead insertion to the end of the pacing measurements. The total procedure duration spanned skin incision to closure. The incidence of lead repositioning during the lead implantation time and during ventricular fibrillation conversion testing was also assessed. The frequency of lead dislocations was recorded at the 3-month follow-up. Mean lead implantation time and total procedure duration of the thin-sized lead (23 ± 22 minutes 76 ± 37 minutes) were not statistically different from the time needed for the conventional-sized lead (22 ± 20 minutes 81 ± 34 minutes). The number of lead repositionings during the lead implantation time was similar (thin-sized lead: 1.4 ± 2.4; conventional-sized lead: 1.1 ± 1.9). An additional lead repositioning was not necessary during ventricular fibrillation conversion testing in 93.4% of the patients with thin-sized and in 94.4% with conventional-sized leads (not significant). At the 3-month follow-up, there were four (6.6%) lead dislocations in the thin-sized and four (6.7%) in the conventional-sized lead group. In conclusion, the downsized lead body of the new defibrillation lead influenced neither ICD procedure duration nor the incidence of lead dislocation during follow-up.</subfield></datafield><datafield tag="533" ind1=" " ind2=" "><subfield code="d">2003</subfield><subfield code="f">Blackwell Publishing Journal Backfiles 1879-2005</subfield><subfield code="7">|2003||||||||||</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">implantable cardioverter defibrillator (ICD)</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">MEINERTZ, THOMAS</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Pacing and clinical electrophysiology</subfield><subfield code="d">New York, NY [u.a.] : Wiley-Blackwell, 1978</subfield><subfield code="g">23(2000), 10, Seite 0</subfield><subfield code="h">Online-Ressource</subfield><subfield code="w">(DE-627)NLEJ243926928</subfield><subfield code="w">(DE-600)2037547-5</subfield><subfield code="x">1540-8159</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:23</subfield><subfield code="g">year:2000</subfield><subfield code="g">number:10</subfield><subfield code="g">pages:0</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://dx.doi.org/10.1046/j.1460-9592.2000.01468.x</subfield><subfield code="q">text/html</subfield><subfield code="x">Verlag</subfield><subfield code="z">Deutschlandweit zugänglich</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-1-DJB</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_NL_ARTICLE</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">23</subfield><subfield code="j">2000</subfield><subfield code="e">10</subfield><subfield code="h">0</subfield></datafield></record></collection>
|
| series2 |
Blackwell Publishing Journal Backfiles 1879-2005 |
| author |
SCHUCHERT, ANDREAS |
| spellingShingle |
SCHUCHERT, ANDREAS misc implantable cardioverter defibrillator (ICD) Effects of a Thin-Sized Lead Body of a Transvenous Single Coil Defibrillation Lead on ICD Implantation |
| authorStr |
SCHUCHERT, ANDREAS |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)NLEJ243926928 |
| format |
electronic Article |
| delete_txt_mv |
keep |
| author_role |
aut aut |
| collection |
NL |
| publishPlace |
Oxford, UK |
| remote_str |
true |
| illustrated |
Not Illustrated |
| issn |
1540-8159 |
| topic_title |
Effects of a Thin-Sized Lead Body of a Transvenous Single Coil Defibrillation Lead on ICD Implantation implantable cardioverter defibrillator (ICD) |
| publisher |
Blackwell Futura Publishing, Inc. |
| publisherStr |
Blackwell Futura Publishing, Inc. |
| topic |
misc implantable cardioverter defibrillator (ICD) |
| topic_unstemmed |
misc implantable cardioverter defibrillator (ICD) |
| topic_browse |
misc implantable cardioverter defibrillator (ICD) |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| hierarchy_parent_title |
Pacing and clinical electrophysiology |
| hierarchy_parent_id |
NLEJ243926928 |
| hierarchy_top_title |
Pacing and clinical electrophysiology |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)NLEJ243926928 (DE-600)2037547-5 |
| title |
Effects of a Thin-Sized Lead Body of a Transvenous Single Coil Defibrillation Lead on ICD Implantation |
| ctrlnum |
(DE-627)NLEJ243910703 |
| title_full |
Effects of a Thin-Sized Lead Body of a Transvenous Single Coil Defibrillation Lead on ICD Implantation |
| author_sort |
SCHUCHERT, ANDREAS |
| journal |
Pacing and clinical electrophysiology |
| journalStr |
Pacing and clinical electrophysiology |
| isOA_bool |
false |
| recordtype |
marc |
| publishDateSort |
2000 |
| contenttype_str_mv |
zzz |
| container_start_page |
0 |
| author_browse |
SCHUCHERT, ANDREAS MEINERTZ, THOMAS |
| container_volume |
23 |
| physical |
Online-Ressource |
| format_se |
Elektronische Aufsätze |
| author-letter |
SCHUCHERT, ANDREAS |
| doi_str_mv |
10.1046/j.1460-9592.2000.01468.x |
| author2-role |
verfasserin |
| title_sort |
effects of a thin-sized lead body of a transvenous single coil defibrillation lead on icd implantation |
| title_auth |
Effects of a Thin-Sized Lead Body of a Transvenous Single Coil Defibrillation Lead on ICD Implantation |
| abstract |
SCHUCHERT, A., et al.: Effects of a Thin-Sized Lead Body of a Transvenous Single Coil Defibrillation Lead on ICD Implantation. In the interest of patients receiving implantable cardioverter defibrillators (ICDs), the clinical benefits of newer and thinner transvenous defibrillation leads have to be determined. The aims of this study were to evaluate the ICD procedure duration and the frequency of lead dislocation at the 3-month follow-up of a new defibrillation lead with a thin-sized lead body and its conventionalsized predecessor. The thin-sized single coil defibrillation lead (Kainox RV, Biotronik; lead body 6.7 Fr) was implanted in 61 patients and the conventional-sized defibrillation lead (SPS, Biotronik; lead body 7.8 Fr) in 60 patients. Both leads were connected to a left-sided, prepectorally implanted Phylax ICD (Biotronik) with active housing. The lead implantation time and total procedure duration were determined. Lead implantation time was defined as the time from lead insertion to the end of the pacing measurements. The total procedure duration spanned skin incision to closure. The incidence of lead repositioning during the lead implantation time and during ventricular fibrillation conversion testing was also assessed. The frequency of lead dislocations was recorded at the 3-month follow-up. Mean lead implantation time and total procedure duration of the thin-sized lead (23 ± 22 minutes 76 ± 37 minutes) were not statistically different from the time needed for the conventional-sized lead (22 ± 20 minutes 81 ± 34 minutes). The number of lead repositionings during the lead implantation time was similar (thin-sized lead: 1.4 ± 2.4; conventional-sized lead: 1.1 ± 1.9). An additional lead repositioning was not necessary during ventricular fibrillation conversion testing in 93.4% of the patients with thin-sized and in 94.4% with conventional-sized leads (not significant). At the 3-month follow-up, there were four (6.6%) lead dislocations in the thin-sized and four (6.7%) in the conventional-sized lead group. In conclusion, the downsized lead body of the new defibrillation lead influenced neither ICD procedure duration nor the incidence of lead dislocation during follow-up. |
| abstractGer |
SCHUCHERT, A., et al.: Effects of a Thin-Sized Lead Body of a Transvenous Single Coil Defibrillation Lead on ICD Implantation. In the interest of patients receiving implantable cardioverter defibrillators (ICDs), the clinical benefits of newer and thinner transvenous defibrillation leads have to be determined. The aims of this study were to evaluate the ICD procedure duration and the frequency of lead dislocation at the 3-month follow-up of a new defibrillation lead with a thin-sized lead body and its conventionalsized predecessor. The thin-sized single coil defibrillation lead (Kainox RV, Biotronik; lead body 6.7 Fr) was implanted in 61 patients and the conventional-sized defibrillation lead (SPS, Biotronik; lead body 7.8 Fr) in 60 patients. Both leads were connected to a left-sided, prepectorally implanted Phylax ICD (Biotronik) with active housing. The lead implantation time and total procedure duration were determined. Lead implantation time was defined as the time from lead insertion to the end of the pacing measurements. The total procedure duration spanned skin incision to closure. The incidence of lead repositioning during the lead implantation time and during ventricular fibrillation conversion testing was also assessed. The frequency of lead dislocations was recorded at the 3-month follow-up. Mean lead implantation time and total procedure duration of the thin-sized lead (23 ± 22 minutes 76 ± 37 minutes) were not statistically different from the time needed for the conventional-sized lead (22 ± 20 minutes 81 ± 34 minutes). The number of lead repositionings during the lead implantation time was similar (thin-sized lead: 1.4 ± 2.4; conventional-sized lead: 1.1 ± 1.9). An additional lead repositioning was not necessary during ventricular fibrillation conversion testing in 93.4% of the patients with thin-sized and in 94.4% with conventional-sized leads (not significant). At the 3-month follow-up, there were four (6.6%) lead dislocations in the thin-sized and four (6.7%) in the conventional-sized lead group. In conclusion, the downsized lead body of the new defibrillation lead influenced neither ICD procedure duration nor the incidence of lead dislocation during follow-up. |
| abstract_unstemmed |
SCHUCHERT, A., et al.: Effects of a Thin-Sized Lead Body of a Transvenous Single Coil Defibrillation Lead on ICD Implantation. In the interest of patients receiving implantable cardioverter defibrillators (ICDs), the clinical benefits of newer and thinner transvenous defibrillation leads have to be determined. The aims of this study were to evaluate the ICD procedure duration and the frequency of lead dislocation at the 3-month follow-up of a new defibrillation lead with a thin-sized lead body and its conventionalsized predecessor. The thin-sized single coil defibrillation lead (Kainox RV, Biotronik; lead body 6.7 Fr) was implanted in 61 patients and the conventional-sized defibrillation lead (SPS, Biotronik; lead body 7.8 Fr) in 60 patients. Both leads were connected to a left-sided, prepectorally implanted Phylax ICD (Biotronik) with active housing. The lead implantation time and total procedure duration were determined. Lead implantation time was defined as the time from lead insertion to the end of the pacing measurements. The total procedure duration spanned skin incision to closure. The incidence of lead repositioning during the lead implantation time and during ventricular fibrillation conversion testing was also assessed. The frequency of lead dislocations was recorded at the 3-month follow-up. Mean lead implantation time and total procedure duration of the thin-sized lead (23 ± 22 minutes 76 ± 37 minutes) were not statistically different from the time needed for the conventional-sized lead (22 ± 20 minutes 81 ± 34 minutes). The number of lead repositionings during the lead implantation time was similar (thin-sized lead: 1.4 ± 2.4; conventional-sized lead: 1.1 ± 1.9). An additional lead repositioning was not necessary during ventricular fibrillation conversion testing in 93.4% of the patients with thin-sized and in 94.4% with conventional-sized leads (not significant). At the 3-month follow-up, there were four (6.6%) lead dislocations in the thin-sized and four (6.7%) in the conventional-sized lead group. In conclusion, the downsized lead body of the new defibrillation lead influenced neither ICD procedure duration nor the incidence of lead dislocation during follow-up. |
| collection_details |
GBV_USEFLAG_U ZDB-1-DJB GBV_NL_ARTICLE |
| container_issue |
10 |
| title_short |
Effects of a Thin-Sized Lead Body of a Transvenous Single Coil Defibrillation Lead on ICD Implantation |
| url |
http://dx.doi.org/10.1046/j.1460-9592.2000.01468.x |
| remote_bool |
true |
| author2 |
MEINERTZ, THOMAS |
| author2Str |
MEINERTZ, THOMAS |
| ppnlink |
NLEJ243926928 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| doi_str |
10.1046/j.1460-9592.2000.01468.x |
| up_date |
2024-07-06T06:55:20.752Z |
| _version_ |
1803811732328546304 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">NLEJ243910703</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20210707191323.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">120427s2000 xx |||||o 00| ||und c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1046/j.1460-9592.2000.01468.x</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)NLEJ243910703</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">SCHUCHERT, ANDREAS</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Effects of a Thin-Sized Lead Body of a Transvenous Single Coil Defibrillation Lead on ICD Implantation</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Oxford, UK</subfield><subfield code="b">Blackwell Futura Publishing, Inc.</subfield><subfield code="c">2000</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">SCHUCHERT, A., et al.: Effects of a Thin-Sized Lead Body of a Transvenous Single Coil Defibrillation Lead on ICD Implantation. In the interest of patients receiving implantable cardioverter defibrillators (ICDs), the clinical benefits of newer and thinner transvenous defibrillation leads have to be determined. The aims of this study were to evaluate the ICD procedure duration and the frequency of lead dislocation at the 3-month follow-up of a new defibrillation lead with a thin-sized lead body and its conventionalsized predecessor. The thin-sized single coil defibrillation lead (Kainox RV, Biotronik; lead body 6.7 Fr) was implanted in 61 patients and the conventional-sized defibrillation lead (SPS, Biotronik; lead body 7.8 Fr) in 60 patients. Both leads were connected to a left-sided, prepectorally implanted Phylax ICD (Biotronik) with active housing. The lead implantation time and total procedure duration were determined. Lead implantation time was defined as the time from lead insertion to the end of the pacing measurements. The total procedure duration spanned skin incision to closure. The incidence of lead repositioning during the lead implantation time and during ventricular fibrillation conversion testing was also assessed. The frequency of lead dislocations was recorded at the 3-month follow-up. Mean lead implantation time and total procedure duration of the thin-sized lead (23 ± 22 minutes 76 ± 37 minutes) were not statistically different from the time needed for the conventional-sized lead (22 ± 20 minutes 81 ± 34 minutes). The number of lead repositionings during the lead implantation time was similar (thin-sized lead: 1.4 ± 2.4; conventional-sized lead: 1.1 ± 1.9). An additional lead repositioning was not necessary during ventricular fibrillation conversion testing in 93.4% of the patients with thin-sized and in 94.4% with conventional-sized leads (not significant). At the 3-month follow-up, there were four (6.6%) lead dislocations in the thin-sized and four (6.7%) in the conventional-sized lead group. In conclusion, the downsized lead body of the new defibrillation lead influenced neither ICD procedure duration nor the incidence of lead dislocation during follow-up.</subfield></datafield><datafield tag="533" ind1=" " ind2=" "><subfield code="d">2003</subfield><subfield code="f">Blackwell Publishing Journal Backfiles 1879-2005</subfield><subfield code="7">|2003||||||||||</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">implantable cardioverter defibrillator (ICD)</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">MEINERTZ, THOMAS</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Pacing and clinical electrophysiology</subfield><subfield code="d">New York, NY [u.a.] : Wiley-Blackwell, 1978</subfield><subfield code="g">23(2000), 10, Seite 0</subfield><subfield code="h">Online-Ressource</subfield><subfield code="w">(DE-627)NLEJ243926928</subfield><subfield code="w">(DE-600)2037547-5</subfield><subfield code="x">1540-8159</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:23</subfield><subfield code="g">year:2000</subfield><subfield code="g">number:10</subfield><subfield code="g">pages:0</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://dx.doi.org/10.1046/j.1460-9592.2000.01468.x</subfield><subfield code="q">text/html</subfield><subfield code="x">Verlag</subfield><subfield code="z">Deutschlandweit zugänglich</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-1-DJB</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_NL_ARTICLE</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">23</subfield><subfield code="j">2000</subfield><subfield code="e">10</subfield><subfield code="h">0</subfield></datafield></record></collection>
|
| score |
7.4020357 |